New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication

Youki Ueda; Midori Takeda; Kyoko Mori; Hiromichi Dansako; Takaji Wakita; Hye-Sook Kim; Akira Sato; Yusuke Wataya; Masanori Ikeda; Nobuyuki Kato

doi:10.1371/journal.pone.0072519

Loading metrics

Open Access

Peer-reviewed

Research Article

New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication

Youki Ueda,

Affiliation Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Shikata-cho, Okayama, Japan
⨯
Midori Takeda,

Affiliation Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Shikata-cho, Okayama, Japan
⨯
Kyoko Mori,

Affiliation Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Shikata-cho, Okayama, Japan
⨯
Hiromichi Dansako,

Affiliation Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Shikata-cho, Okayama, Japan
⨯
Takaji Wakita,

Affiliation Department of Virology II, National Institute of Infectious Disease, Toyama, Shinjuku-ku, Tokyo, Japan
⨯
Hye-Sook Kim,

Affiliation Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Okayama University, Tsushima-naka, Okayama, Japan
⨯
Akira Sato,

Affiliation Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Okayama University, Tsushima-naka, Okayama, Japan
⨯
Yusuke Wataya,

Affiliation Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Okayama University, Tsushima-naka, Okayama, Japan
⨯
Masanori Ikeda,

Affiliation Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Shikata-cho, Okayama, Japan
⨯
Nobuyuki Kato

* E-mail: nkato@md.okayama-u.ac.jp

Affiliation Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Shikata-cho, Okayama, Japan
⨯

New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication

Youki Ueda,
Midori Takeda,
Kyoko Mori,
Hiromichi Dansako,
Takaji Wakita,
Hye-Sook Kim,
Akira Sato,
Yusuke Wataya,
Masanori Ikeda,
Nobuyuki Kato

Published: August 30, 2013
https://doi.org/10.1371/journal.pone.0072519

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Hepatitis C virus
Is the Subject Area "Hepatitis C virus" applicable to this article?

Thanks for your feedback.
Antimalarials
Is the Subject Area "Antimalarials" applicable to this article?

Thanks for your feedback.
Genomics
Is the Subject Area "Genomics" applicable to this article?

Thanks for your feedback.
Luciferase assay
Is the Subject Area "Luciferase assay" applicable to this article?

Thanks for your feedback.
Artemisinin
Is the Subject Area "Artemisinin" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Malaria
Is the Subject Area "Malaria" applicable to this article?

Thanks for your feedback.